Japan


With an ageing population of over 127 million, it is no wonder that the Japanese Pharmaceutical market is reportedly moving towards $80 billion.   In the period 2011-2012, Japan conducted over 29% of trials in APAC and during that period, 501 clinical trials were conducted at over 507 sites.

Choosing the right partner
It is widely accepted that conducting clinical trials has unique challenges and partnering with the right partner that has the expertise, capability and experience is the first step you need to take.

Clnical and regulatory expertise
Our experts have extensive experience of supporting global and local pharmaceutical, biotech and medical device organisations in their clinical development programs. With deep therapeutic experience particularly in oncology, CNS and infectious disease; excellent relationships with regulatory bodies and a well-developed network with investigative sites, they break down the barriers of reaching your milestones.

Full range of services 
ICON can provide you with a full range of clinical development services to support global, pan Asia Pacific, and local trials in Japan.  With locally based project management capabilities and regulatory expertise, you will get the insight, innovation and performance that will make a difference to cycle times and quality of data.  

Service options 

  • Medical Safety and Monitoring
  • Clinical Operations (Phase II – III)
  • Study Start-up and Regulatory Affairs
  • Medical Writing
  • Regulatory and Strategic Consultancy
  • Commercialisation & Outcomes
  • Strategic Resourcing and FSP Services

Strong heritage and growing
ICON Japan was established in 1995 and we continue to grow and strengthen our presence there.  We now have offices located in Tokyo and Osaka.